Homespms

  • New Biomarkers identified for Progressive Multiple Sclerosis

    • July 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Roche announces long term disability data for Ocrevus in PPMS patients

    • June 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Atrophied Brain Lesion Volume could be a new biomarker for Progressive MS, study suggests

    • June 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Recent study investigated RRMS to SPMS progression in MS patients

    • June 1, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New Stem cell based treatment investigated for SPMS

    • May 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • SPMS patients have higher cognitive decline than RRMS patients, study reports

    • April 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Roche Acquires regenerative MS therapy program focused on remyelination

    • April 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • NATCO launches generic version of Aubagio for MS in INDIA

    • April 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • First patient enrolled in Ph 3 Trial of ADS-5102 in MS Patients with Walking Impairment

    • April 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Novel PET imaging agent to assess treatments for neurological diseases

    • April 4, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more
  • 1
  • 2